GMI PEGylated Drugs Market Haga clic para leer
  • Comentarios

GMI

PEGylated Drugs Market

Publicado el en “Salud y Estado Físico, Salud y Estado Físico”, Idioma — English. 3 páginas.
PEGylation refers to change in structure of protein by linking one or more polyethylene glycol (PEG) chains. It is easily soluble in organic and aqueous solutions and is non-toxic in nature. The chain binds to the drugs covalently and make it sterically stable. The polymer thus formed is non-toxic, non-antigenic, non-immunogenic, and highly water soluble. It further increases half-life of the drug and reduces dose frequency by preventing renal excretion of drugs. Más
Growing public apprehensiveness pertaining to aesthetic appearance will drive scar treatment market growth. Scars result as a consequence of the natural healing process of the body in response to tissue damage caused by various factors such as accidental injuries, cuts during surgical procedures, burns, scalds, injections, and tattoos. Side effects of scarring such as post- traumatic stress, emotional trauma, loss of self-esteem, pain, itching and tenderness will boost treatment adoption over th Más
Suscríbase GRATIS

Otras ediciones de “GMI”

Ver todas las ediciones